Navigation Links
Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference
Date:3/4/2013

CRANBURY, N.J., March 4, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the Cowen & Company 33rd Annual Health Care Conference on Tuesday, March 5, 2013, at 9:20 a.m. Eastern Time.  The conference will be held at the Boston Marriott Copley Place, Boston, MA.

Carl Spana , Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs. A live audio broadcast will be available on the "Investors" section of Palatin's website at www.palatin.com. The live audio broadcast will be available through March 12, 2013.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on February 14, 2013
2. Palatin Technologies, Inc. To Report Fiscal Year 2013 Second Quarter Results; Teleconference and Webcast to be held on February 14, 2013
3. Palatin Technologies, Inc. to Present at 15th Annual BIO CEO & Investor Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
5. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
6. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
7. Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
8. Palatin Technologies Reports Positive Results for Phase 2B Bremelanotide Female Sexual Dysfunction Trial
9. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of ... report to their offering. ... The study scope includes key agricultural ... synthetic biology tools and genome editing tools); synthetic biology-enabled chemicals ... and products are analyzed to determine present and future market ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced today ... and enhance training plan management for consistent implementation of standards and regulatory requirements ... SHL Group to help improve and streamline their training and employee development programs, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... on March 22 in Philadelphia. The event was offered by the Chamber of ... Roundtable featured breakout groups and interaction with speakers who are leaders in ...
(Date:3/28/2017)... 2017 Summary This report provides ... and its partnering interests and activities since 2010. Description ... in-depth insight into the partnering activity of one of the ... reports are prepared upon purchase to ensure inclusion of the ... The report will be delivered in PDF format within 1 ...
Breaking Biology Technology:
(Date:2/26/2017)... 2017  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announces the appointment ... "Too often, too many offenders return to ... are trying to tackle this ongoing problem and ... family members. While significant steps are underway, Securus continues ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
(Date:2/21/2017)... 2017 Der weltweite Biobanking-Sektor wird ... einem Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen ... gilt, um diese Prognose zu realisieren. ... Zu den ... finanziellen Mittel für die Biobank, die Implementierung Zeit sparender ...
Breaking Biology News(10 mins):